SCHEMBL28034036

SCHEMBL28034036

NC(=O)c1ccccc1C(=O)NC[C@H]1CO1

nearest known ligand 0.47

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
HPGD P15428 3/20 0.47
RAB9A P51151 5/20 0.46
NPC1 O15118 4/20 0.46
SMN1; SMN2 Q16637 2/20 0.46
L3MBTL1 Q9Y468 2/20 0.45
KDM4E B2RXH2 2/20 0.45
ALOX15 P16050 2/20 0.45
HSD17B10 Q99714 2/20 0.45
LMNA P02545 1/20 0.43
TSHR P16473 2/20 0.43
GAA P10253 1/20 0.43
HTT P42858 1/20 0.43
ALDH1A1 P00352 2/20 0.42
POLB P06746 1/20 0.42
NPSR1 Q6W5P4 1/20 0.42
MTNR1A P48039 1/20 0.41
MEN1 O00255 1/20 0.41
KMT2A Q03164 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29446949 1.00 HPGD (0.47) HPGDRAB9ANPC1SMN1; SMN2L3MBTL1
SCHEMBL28034038 1.00 HPGD (0.47) HPGDRAB9ANPC1SMN1; SMN2L3MBTL1
SCHEMBL29446948 1.00 HPGD (0.47) HPGDRAB9ANPC1SMN1; SMN2L3MBTL1
SCHEMBL29446950 1.00 HPGD (0.47) HPGDRAB9ANPC1SMN1; SMN2L3MBTL1
SCHEMBL7880809 1.00 HPGD (0.47) HPGDRAB9ANPC1SMN1; SMN2L3MBTL1
SCHEMBL30336486 0.86 KMT2A (0.54) HPGDRAB9ANPC1SMN1; SMN2L3MBTL1
SCHEMBL28994501 0.86 KMT2A (0.54) HPGDRAB9ANPC1SMN1; SMN2L3MBTL1
SCHEMBL27483440 0.83 HPGD (0.55) HPGDRAB9ANPC1SMN1; SMN2L3MBTL1
SCHEMBL4585320 0.81 HPGD (0.43) HPGDRAB9ANPC1SMN1; SMN2L3MBTL1
SCHEMBL11150836 0.81 RAB9A (0.56) HPGDRAB9ANPC1SMN1; SMN2KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-111393428-B Preparation method of rivaroxaban impurity 南京国星生物技术研究院有限公司 2022-03-15 CN disclosed
CN-111393428-A Method for preparing rivaroxaban impurity 南京国星生物技术研究院有限公司 2020-07-10 CN disclosed
CN-104961646-A Mosapride active metabolites, preparation method and uses thereof UNIV SHENYANG PHARMACEUTICAL 2015-10-07 CN disclosed